The Federal Trade Commission (FTC) and the State of Georgia filed a lawsuit against the Stem Cell Institute of America for marketing stem cell therapy using false claims that it can cure arthritis, joint pain, and many other orthopedic ailments.
The company’s co-founders Steven Peyroux and Brent Detelich, and two other related entities, Physicians Business Solutions, and Superior Healthcare were also named as defendants in the case.
In the complaint, the federal consumer protection watchdog alleged that Stem Cell Institute of America and its co-defendants violated certain provisions of the FTC Act. Georgia Attorney General Christopher Carr alleged that the defendants did not comply with the state’s Fair Business Practices Act (FBPA).
Stem Cell Institute of America targeted seniors with baseless joint pain cure-all marketing scheme
The FTC and Attorney General Carr alleged that the defendants misrepresented stem cell therapy as an effective treatment for various orthopedic conditions including arthritis, joint pain, plantar fasciitis, osteoarthritis, and pain due to injuries or aging.
